Blog
Is the Vanguard S&P 500 ETF the Smartest Investment You Can Make Before March Ends?
Despite the volatility we've seen in the equity markets this year, the S&P 500 (SNPINDEX: ^GSPC) has mostly traded sideways. Its year-to-date return has only varied between up 2% to 3% and down
Rumble (RUM) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, March 5, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Prediction: While Big Tech Grabs Headlines, These Small AI Stocks Could Outperform
Perhaps no stock has symbolized the artificial intelligence (AI) era more than Nvidia. Thanks to AI, it became the first company to reach a $4 trillion market cap, then beat its own record a few
Global Partners LP COO Sells Nearly $740000 Worth of Units
Mark Romaine, Chief Operating Officer of Global Partners LP (NYSE:GLP), reported the direct sale of 15,611 common units across multiple transactions between March 16 and March 18, 2026, as disclosed
The Social Security Fairness Act Paid Out $17 Billion in Retroactive Benefits. Here's Who Qualifies.
Signed into law on Jan. 5, 2025, the Social Security Fairness Act represents one of the most significant changes to America's retirement system in recent history. At its core, the legislation
The Tech Stock With More Potential Than Any Cryptocurrency
Cryptocurrency has been having a rough year. Since peaking at over $122,000 late last year, Bitcoin has tumbled to $73,986. Year to date, it's down 15.3% and dipped below $64,000 last month.
Now
Could Buying $10,000 of Sandisk Make You a Millionaire?
Sandisk (NASDAQ: SNDK) has been on one heck of a run since its spinoff from Western Digital (NASDAQ: WDC) last year. The flash-memory maker's stock has climbed nearly 2,000% since its market debut
Better Cybersecurity Stock: Okta vs. Zscaler
If you spend your workdays in front of a computer, there's a solid chance you're required to keep your company safe from bad actors through either Okta (NASDAQ: OKTA) or Zscaler (NASDAQ: ZS). Both
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
On March 10, 2026, Harold Bernstein, President, R&D & Chief Medical Officer of Maze Therapeutics (NASDAQ:MAZE), reported the exercise of 30,000 stock options and immediate sale of the underlying
2 Financial Stocks That Could Double Over the Next 5 Years
With markets trending lower, this is an excellent time to find some good stocks at lower valuations and entry points.
The financial sector is a particularly good place to look, as the sector has
If You Invested $10,000 in Tesla Stock 10 Years Ago, Here's How Much You'd Have Today
With its direct-to-consumer sales strategy, intense focus on product innovation, and premium positioning, Tesla (NASDAQ: TSLA) has become a globally recognized automotive enterprise. And long-term
1 Cryptocurrency to Buy Before It Soars Over 1,300%, According to an Expert Analyst
After surging to new all-time highs in 2025, the cryptocurrency market has cooled significantly in 2026. The CoinMarketCap 20 Index is down more than 30% since it was established as a way to track
3 Less-Obvious Benefits of Retiring Late
For many people, retiring early is the ultimate dream. You can ditch the daily alarm clock, reclaim your time, and do all of the things you were too busy for while you were working.
But while
This $9 Million Solar Bet Lands Amid an 82% Stock Surge and $3 Billion Revenue Year
PlusTick Management opened a new position in Sunrun (NASDAQ:RUN) during the fourth quarter, acquiring 500,000 shares worth $9.20 million, according to a February 17, 2026, SEC filing.
According to a
Century Aluminum CEO Sells 150000 Shares as Aluminum Prices Soar
Jesse Gary, President and CEO of Century Aluminum Company (NASDAQ:CENX), reported the sale of 150,000 shares for a transaction value of ~$8.32 million on March 16, 2026, according to a SEC Form 4
Prediction: 2 Things That Will Happen to Alibaba in 2026
Alibaba Group (NYSE: BABA) has spent the past few years navigating regulatory pressure, intense competition, and shifting investor sentiment. But as the company enters 2026, the picture is becoming
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset
DAFNA Capital Management reported selling 222,847 shares of Syndax Pharmaceuticals (NASDAQ:SNDX) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.89 million based on
Is the Stock Market Sending a Warning Signal About Artificial Intelligence (AI) Stocks?
You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors
Ralliant Director Purchases 2350 Shares as Institutional Investors Push for Stock Buyback
Kate Mitchell, Director of Ralliant (NYSE:RAL), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026.
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February
Vita Coco CFO Sells 4000 Shares as Stock Sets to Join S&P SmallCap 600
Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), disclosed the sale of 4,000 shares of common stock on March 17, 2026 and March 18, 2026, as detailed in the SEC
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash
DAFNA Capital Management reported a buy of 720,000 shares of Biohaven (NYSE:BHVN) in a February 17, 2026, SEC filing, with the estimated transaction value at $8.92 million based on quarterly average
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
RTW Investments initiated a new stake in Apellis Pharmaceuticals (NASDAQ:APLS), acquiring 7,666,764 shares in the fourth quarter, according to a February 17, 2026, SEC filing.
An SEC filing dated
What Happens to Your Investments If the Stock Market Crashes?
More than half of U.S. investors feel pessimistic about the market's future, according to the most recent weekly survey from the American Association of Individual Investors, published on March 18
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
RTW Investments disclosed a significant buy of Cogent Biosciences (NASDAQ:COGT) in its February 17, 2026, SEC filing, adding 4,124,755 shares in a trade estimated at $115.95 million based on


